Skip to main content

RDY 18 (Methylphenidate Hydrochloride Extended-Release 18 mg)

Pill with imprint RDY 18 is Purple, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 18 mg. It is supplied by Dr. Reddy's Laboratories, Inc..

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 18 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for RDY 18

Methylphenidate Hydrochloride Extended-Release

Imprint
RDY 18
Strength
18 mg
Color
Purple
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Cns stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Dr. Reddy's Laboratories, Inc.
National Drug Code (NDC)
43598-0438

Get help with Imprint Code FAQs.

Related Images for "RDY 18"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.